AKT1 and lung cancer: Thus, our data indicate that the signal pathway of BTC-EGFR–PI3K–Akt–Erk-CXCL8 plays an important role in the inflammatory microenvironment in lung cancer, as a novel therapeutic approach to lung cancer.